Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Assessment of bleeding after concomitant administration of antiplatelet and anticoagulant agents in lower limb arthroplasty.

Assessment of bleeding after concomitant administration of antiplatelet and anticoagulant agents in lower limb arthroplasty. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Assessment of bleeding after concomitant administration of antiplatelet and anticoagulant agents in lower limb arthroplasty. Abstract Text:

    ola e dahlOla E Dahl,mats ogrenMats Ogren,giancarlo agnelliGiancarlo Agnelli,bengt i erikssonBengt I Eriksson,alexander t cohenAlexander T Cohen,patrick mouretPatrick Mouret,nadia rosencherNadia Rosencher,anders bylockAnders Bylock,seva panfilovSeva Panfilov,magnus anderssonMagnus Andersson,ola e dahlOla E Dahl,mats ogrenMats Ogren,giancarlo agnelliGiancarlo Agnelli,bengt i erikssonBengt I Eriksson,alexander t cohenAlexander T Cohen,patrick mouretPatrick Mouret,nadia rosencherNadia Rosencher,anders bylockAnders Bylock,seva panfilovSeva Panfilov,magnus anderssonMagnus Andersson,

    In an analysis of the Melagatran Thrombosis Prophylaxis in Orthopedic Surgery (METHRO) III study, we evaluated whether concomitant administration of aspirin (ASA) and non-steroidal anti-inflammatory drugs (NSAIDs) with the direct thrombin inhibitor melagatran/ximelagatran or the low-molecular-weight heparin enoxaparin increased bleeding in patients undergoing major joint surgery. Further objectives were to compare the influence of the timing of initial postoperative administration of melagatran/ximelagatran on bleeding in orthopedic patients receiving ASA/NSAIDs and in comparison with the preoperative administration of enoxaparin. ASA or NSAIDs in conjunction with melagatran/ximelagatran or enoxaparin did not increase bleeding. Bleeding rates were not significantly different, irrespective of the timing of the initial postoperative dose of melagatran/ximelagatran (4-8 vs. 4-12 h) when compared with preoperative (12 h) administration of enoxaparin. Transfusion rates were significantly lower with administration of melagatran/ximelagatran compared with enoxaparin.

    Assessment of bleeding after concomitant administration of antiplatelet and anticoagulant agents in lower limb arthroplasty. Publishing Authors By Initials

    oe dahlOE Dahl,m ogrenM Ogren,g agnelliG Agnelli,bi erikssonBI Eriksson,at cohenAT Cohen,p mouretP Mouret,n rosencherN Rosencher,a bylockA Bylock,s panfilovS Panfilov,m anderssonM Andersson,oe dahlOE Dahl,m ogrenM Ogren,g agnelliG Agnelli,bi erikssonBI Eriksson,at cohenAT Cohen,p mouretP Mouret,n rosencherN Rosencher,a bylockA Bylock,s panfilovS Panfilov,m anderssonM Andersson,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Assessment of bleeding after concomitant administration of antiplatelet and anticoagulant agents in lower limb arthroplasty. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Pathophysiology of haemostasis and thrombosis

    VOLUME: 35

    Page Numbers: 428-34

    Journal Abbreviation: Pathophysiol. Haemost. Thromb.

    ISSN: 1424-8832

    DAY: 13

    MONTH: 06

    YEAR: 2006

    Assessment of bleeding after concomitant administration of antiplatelet and anticoagulant agents in lower limb arthroplasty. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101142710

    Assessment of bleeding after concomitant administration of antiplatelet and anticoagulant agents in lower limb arthroplasty. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Assessment of bleeding after concomitant administration of antiplatelet and anticoagulant agents in lower limb arthroplasty. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Assessment of bleeding after concomitant administration of antiplatelet and anticoagulant agents in lower limb arthroplasty.

    AFFILIATION: International Surgical Thrombosis Forum, Thrombosis Research Institute, London, UK. oladahl@start.no

    Country: Switzerland

    Switzerland Research PublicationSwitzerland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Pathophysiol Haemost Thromb

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Assessment of bleeding after concomitant administration of antiplatelet and anticoagulant agents in lower limb arthroplasty Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News